Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population–based cohort study
Chio Yokose, Na Lu, Hui Xie, Lingyi Li, Yufei Zheng, Natalie McCormick, Sharan K. Rai, J. Antonio Aviña-Zubieta and Hyon K. Choi
CMAJ September 30, 2019 191:E1070-E1077
[PDF]
Health Canada needs to act on laboratory-developed diagnostics
Kelly Holloway, Fiona A. Miller, François Rousseau, Alberto Gutierrez and Stuart Hogarth
CMAJ September 30, 2019 191:E1067-E1069
[PDF]
Cases: Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus
Xin Wang, Maxime Billick, Danny Monsour and Jessica Liu
CMAJ September 30, 2019 191:E1078-E1081
[PDF]
Clinical Images: Skin cancer development in a birthmark
Alexandra C. Finstad and Mark G. Kirchhof
CMAJ September 30, 2019 191:E1082
[PDF]
Encounters: Wild to our marrow
Kat Cameron
CMAJ September 30, 2019 191:E1083
[PDF]
How work hours affect medical resident performance and wellness
Caroline Mercer
CMAJ September 30, 2019 191:E1086-E1087
[PDF]
Hormone therapy study restokes debate over breast cancer risk
Lauren Vogel
CMAJ September 30, 2019 191:E1088-E1089
[PDF]
Health Services: Canada's health care crisis is a ballot box issue, says CMA
Lauren Vogel
CMAJ September 30, 2019 191:E1090
[PDF]
Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations
Joan Trujols, M. Josefa Campins and Elisa Ribalta
CMAJ September 30, 2019 191:E1084
[PDF]
The authors respond to "Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations"
Andreea A. Artenie and Julie Bruneau
CMAJ September 30, 2019 191:E1085
[PDF]